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Although viral gene expression occurs in the peripheral nervous system during acute infection, bovine
herpesvirus 1 (BHV-1) gene expression is extinguished, many neurons survive, and latency ensues. The only
abundant viral transcript expressed during latency is the latency-related (LR) RNA, which is alternatively
spliced in trigeminal ganglia during acute infection (L. Devireddy and C. Jones, J. Virol. 72:7294–7301, 1998).
A subset of neurons express a protein encoded by the LR gene and the LR protein (LRP) is associated with
cyclin-dependent kinase 2 (Cdk2)/cyclin complexes during productive infection (Y. Jiang, A. Hossain, M. T.
Winkler, T. Holt, A. Doster, and C. Jones, J. Virol. 72:8133–8142, 1998). LR gene products inhibit cell cycle
progression, perhaps as a result of LRP interacting with Cdk2/cyclin complexes. During acute infection,
expression of cyclin A occurs in trigeminal ganglionic neurons (L. M. Schang, A. Hossain, and C. Jones,
J. Virol. 70:3807–3814, 1996). Inappropriate expression of G1- and S-phase cyclins can initiate programmed
cell death (PCD), apoptosis, in neurons, suggesting that LR gene products inhibit PCD. To test this hypothesis,
we modified an assay to measure PCD frequency in transiently transfected cells. C6-ceramide, fumonisin B1
(FB1), or etoposide was used to initiate PCD following transfection of cells with plasmids expressing LR gene
products and the b-galactosidase gene. Transfected cells that survived were quantified by counting b-galac-
tosidase-positive cells. Plasmids that expressed LR gene products promoted survival of monkey kidney (CV-1),
human lung (IMR-90), or mouse neuroblastoma (neuro-2A) cells after induction of PCD. Plasmids with
termination codons at the beginning of LR open reading frames or deletion of sequences that mediate splicing
of LR RNA did not promote cell survival following PCD induction. We hypothesize that LR gene products play
a role in promoting survival of postmitotic neurons during acute infection or reactivation.
Bovine herpesvirus 1 (BHV-1) is a significant bovine patho-
gen, which causes respiratory disease, abortion, genital disease,
or occasionally encephalitis (reviewed in reference 29). Like
other members of the Alphaherpesvirinae subfamily, BHV-1
establishes latent infection in sensory ganglionic neurons (re-
viewed in reference 29). Viral DNA persists in these neurons
for the lifetime of infected cattle but can periodically reactivate
and spread. In contrast to the 70 to 80 viral genes expressed
during productive infection, latency-related (LR) RNA is the
only abundant viral transcript detected in latently infected neu-
rons. A small fraction of LR RNA is polyadenylated and al-
ternatively spliced in trigeminal ganglia (TG), suggesting that
this RNA is translated into an LR protein (LRP) (8, 21, 27).
LR gene products inhibit S-phase entry, and LRP is associated
with cyclin-dependent kinase 2 (Cdk2)/cyclin complexes (27,
46). Cdk2/cyclin complexes regulate the transition from G1 to
S to G2 (reviewed in reference 19) and are required for DNA
replication (30). Cdk2 activity is stimulated after herpes sim-
plex virus type 2 (HSV-2) infection (22) and is important for
HSV-1 infection (47, 48). It is reasonable to hypothesize that
members of the Alphaherpesvirinae subfamily utilize Cdk2 and
perhaps other Cdks to stimulate viral DNA replication and
transcription. Although the functional significance of the in-
teractions between LRP and Cdk2/cyclin is not known, these
interactions are likely to be important.
Herpesviruses can induce programmed cell death (PCD), or
apoptosis, when cultured cells are infected (reviewed in refer-
ences 18 and 51). BHV-1 also induce PCD after infection of
cultured cells (9, 14–17) or calves (53). Neuronal PCD occurs
during neurodegenerative disorders, trauma, or imbalances of
growth factors and cytokines (reviewed in references 10, 25,
and 54). Expression of cell cycle regulatory proteins is fre-
quently observed in neurons undergoing PCD, suggesting that
altered Cdk activity initiates PCD (reviewed in reference 49).
The HSV-1 US3 kinase plays a role in preventing PCD (1, 33),
suggesting that regulation of PCD is crucial for pathogenesis.
Inhibiting neuronal damage and/or PCD may also be impor-
tant because the primary site of latency for BHV-1 is sensory
neurons.
This study demonstrated that LR gene products inhibit or
delay PCD following transient transfection of CV-1 cells, low-
passage human fibroblasts, or mouse neuroblastoma cells. Al-
though there was a correlation between LR protein expression
and cell survival, we cannot exclude the possibility that LR
RNA by itself is important. We hypothesize that LR gene
products promote neuronal survival by inhibiting PCD.
MATERIALS AND METHODS
Cells. Cells were plated at a density of 5 3 105/100-mm-diameter plastic dish
in Earle’s modified Eagle’s medium supplemented with 5% fetal bovine serum
(FBS). CV-1 cells were split at a 1:5 ratio every 4 or 5 days. Human primary lung
fibroblasts (IMR-90 cells) were obtained from the American Type Culture Col-
lection (ATCC; Rockville, Md. and split in a 1:3 ratio every 5 days. IMR-90 cells
were split five to seven times and then discarded. Mouse neuroblastoma (neuro-
2A; ATCC CCL131) cells were grown in Earle’s minimal essential medium
supplemented with 5% FBS. All media contained penicillin (10 U/ml) and
streptomycin (100 mg/ml).
b-Gal cotransfection and analysis of cell death. To quantitatively measure cell
death, we modified a previously described assay (23, 24, 31, 35) that entails
cotransfecting a b-galactosidase (b-Gal) expression plasmid (pCMV-b-gal) and
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a gene of interest by calcium phosphate precipitation (5, 13). If a gene induces
PCD or is toxic to cells, the number of b-Gal-positive cells decrease. Conversely,
a gene that inhibits PCD maintains the number of b-Gal-positive cells after
inducing PCD. Cells were plated at a density of 2 3 105/well in six-well plastic
plates (35 mm/well) 12 to 16 h prior to transfection. After transfection, a glycerol
shock (20% glycerol–phosphate-buffered saline [PBS]) was performed for 4 min,
followed by two PBS washes. Fresh medium containing 5% FCS and 5 mM
sodium butyrate was added to the cells to facilitate transfection efficiency. Cells
were then treated (37°C for 48 h) with 25 mM fumonisin B1 (FB1) (5, 52) or 15
mM C6-ceramide (2, 40) to initiate PCD.
Neuro-2A cells were transfected as described above except that the glycerol
shock was not performed and cultures were treated with 2.5 mM sodium bu-
tyrate. Cultures were subsequently treated with 15 mM etoposide (catalogue no.
E1383; Sigma) to induce PCD. Etoposide is an anticancer agent that inhibits
topoisomerase II. Cells treated with etoposide have higher levels of DNA dam-
age (double- and single-stranded DNA), especially cells that are in late S and G2
(reviewed in references 13a and 39). At 48 h after etoposide treatment, b-Gal-
positive cells were observed microscopically. The number of stained blue cells
was counted by identifying the same area of each plate. At least five fields per
plate were counted (.500 cells), and the average number of cells per field was
calculated.
Plasmids. The various constructs (see Fig. 3) were generated by standard
recombinant techniques and as previously described (21, 46). To construct
LRTDSmaI, plasmid LRTwt was digested with SmaI, and the large fragment was
FIG. 1. Induction of PCD by FB1 or C6-ceramide. CV-1 cells were cotransfected with plasmid pCMV-b-gal (2 mg) and the designated plasmid (4 mg). After
transfection, cells were treated with 20 mM C6-ceramide for 48 h, fixed, and stained with Bluo-Gal 5-bromo-3-indolyl-b-D-galactopyranoside for 24 h. As a control, some
cultures were treated with PBS. Morphology of typical blue cells is shown.
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purified and religated. LRTstop contains a stop codon linker in the SphI sites
located at positions 781 and 812 of the LR gene. This was accomplished by
insertion of the PstI fragment containing the first 981 nucleotides (nt) of the LR
gene into the pBlueBacHis vector and digestion with SphI; large fragment was
purified, and an SphI linker containing stop codons in all three open reading
frames (ORFs) (59-CAGAATTCTAGTTAGTTAGCATG-39) was ligated into
the amino terminus of LR ORF2. This linker also contains an EcoRI site to
facilitate screening.
pCMVCpIAP (hereafter referred to as CpIAP), a plasmid that contains the
baculovirus antiapoptotic gene iap (6), was obtained from Lois Miller (University
of Georgia, Athens). The adenovirus E1A gene was obtained from E. White
(Rutgers University, Piscataway, N.J.). pCMV-b-gal was purchased from Clon-
tech (Palo Alto, Calif.). Plasmid E2.6 contains the BHV-1 ICP0 gene (bICP0)
and was obtained from M. Schwyzer (Zurich, Switzerland). Two rounds of
cesium chloride centrifugation were used to purify plasmids after bacteria were
lysed with alkali and sodium dodecyl sulfate (SDS).
Preparation of RNA and RT-PCR. RNA from transfected CV-1 cells was
prepared as described previously (8, 21). RNA was quantified spectrophoto-
metrically (optical density at 260 nm) and stored at 280°C in 3 volumes of
ethanol. Reverse transcriptase PCR (RT-PCR) and LRT primers were described
previously (21). The L3A upstream sense primer spans nt 1672 to 1693 (59-CG
CTCCCCTTCGTCCCTCCTCA-39). The L3A downstream antisense primer is
complementary to nt 1835 to 1815 (59-GACGAGACCCCCGATTGCCG-39).
The L3B upstream sense primer spans nt 1755 to 1775 (59-TTCTCTGGGCTC
GGGGCTGC-39). The downstream antisense primer is complementary to 1924
to 1947 (59-AGAGGTCGACAAACACCCGCGGT-39). The nucleotide num-
bering system for the LR gene was previously described (32). Actin primers to
screen RT reactions were derived from rat sequences. The Actin1 primer is
(59-GTGGGGCGCCCCAGGCACCA-39). The Actin2 primer is (59-CTCCTT
AATGTCACGCACGATTTC-39). RNA samples were treated with 2 U of
DNase 1 (RNase free) and 10 U of RNasin (Promega, Madison, Wis.) per mg of
total RNA for 30 min at 20°C. RT-PCR was performed essentially as described
previously (21, 46). Amplified products were detected by 2% agarose gel elec-
trophoresis.
Western blot analysis. Preparation of extracts and Western blot analysis were
performed as described previously (4, 21, 22, 46). The P2 antibody is directed
against an 18-amino-acid peptide near the N terminus of LR ORF2 and specif-
ically recognizes a 40 kDa protein in infected or transiently transfected cells (21,
27).
Statistical analysis. Statistical analysis was performed with the SSPS program,
student version. Values shown in Fig. 2 and 6 are normalized to those for the
vector-alone transfected controls (defined as 0). Data are average mean differ-
ences from vector-alone control (n 5 7). P values represent the probability that
the result occurred by chance, using 95% confidence; P , 0.05 is statistically
significant. Error bars represent the standard error of the mean differences.
RESULTS
Analysis of PCD in cells transfected with the LR gene. Pre-
vious studies concluded LR gene products inhibit G1-to-S tran-
sition (46) and LRP is associated with Cdk2/cyclin complexes
(27). Several independent studies have concluded that cell
cycle factors, in addition to regulating cell cycle progression,
play a role during PCD (11, 38, 41–43, 49). To test whether the
LR gene influences cell survival, we modified a b-Gal cotrans-
fection assay (24, 27, 31, 35) to measure the effects of various
genes on PCD. Two sphingoid bases, FB1 or C6-ceramide, can
induce PCD in mammalian cells (2, 5, 40, 52). Cells treated
with FB1 or C6-ceramide exhibit the hallmarks of PCD: DNA
laddering, formation of apoptotic bodies, and condensation of
chromatin. Both agents kill approximately 80% of treated cells
(5, 52). C6-ceramide is one of the central regulators of the
sphingomyelin signal transduction pathway, a ubiquitous sig-
naling system that links specific cell surface receptors and
environmental stresses to the nucleus. The sphingomyelin
pathway is crucial during PCD initiated by tumor necrosis
factor alpha, FAS, and ionizing radiation (2, 26, 40). FB1 in-
hibits ceramide synthase, the enzyme that synthesizes complex
sphingolipids (including ceramide). We have characterized the
differences between the mechanism of PCD initiated by these
two sphingoid bases (5, 52) and thus are useful reagents for
analyzing PCD. Monkey kidney (CV-1) and primary human
lung (IMR-90) cells were used for these studies because these
cell types are nontumorigenic and susceptible to PCD.
A plasmid that expresses LR gene products (LRTwt) en-
hanced cell survival after treatment with C6-ceramide or FB1,
as judged by an increase in the number of surviving b-Gal-
positive CV-1 cells (Fig. 1 and 2A). As expected, the frequency
of b-Gal-positive cells was reduced dramatically when CV-1
cells were cotransfected with pCDNA/3.1 and pCMV-b-Gal
followed by treatment with C6-ceramide or FB1 (5) (Fig. 1). A
plasmid that expresses bICP0 was used as a control because it
contains sequences that overlap the LR gene. Overexpression
of bICP0 in CV-1 cells reduced the number of b-Gal-positive
CV-1 cells (Fig. 1) independent of treatment with C6-ceramide
or FB1, suggesting that it was toxic. After transfection with
bICP0, the b-Gal-positive cells were smaller and rounded com-
pared to those transfected with LRTwt or pCDNA/3.1 (Fig. 1).
Further studies will be necessary to determine whether bICP0
induces PCD or was merely toxic. The adenovirus E1A gene,
which induces PCD (7, 45), reduced the number of b-Gal-
positive cells independent of treatment with FB1 or C6-cer-
amide (Fig. 2A). As expected, CpIAP enhanced the survival of
cells after treatment with C6-ceramide or FB1 (Fig. 2A).
To ensure that these findings were not a peculiarity of CV-1
cells, this study was repeated with IMR-90 cells. After trans-
fection with LRTwt or CpIAP, a higher frequency of cells
survived C6-ceramide or FB1 treatment relative to cultures
transfected with the blank expression vector (Fig. 2B). LRTwt
and CpIAP were statistically different from the vector alone.
However, the difference between LRTwt and CpIAP was not
statistically significant. E1A reduced the number of blue cells
FIG. 2. Regulation of PCD by LRT. CV-1 cells (A) or IMR-90 cells (B) were
transfected with pCMV-b-gal (2 mg) and the designated plasmid (4 mg). After
transfection, cells were treated with 25 mM FB1 or 15 mM C6-ceramide for 48 h,
and b-Gal-positive cells were identified. The number of blue cells in five fields
was counted. The blue cells that survived FB1 or C6-ceramide treatment were
divided by the blue cells in control cultures to yield percent cell survival; the data
presented are normalized to that for empty vector control (pCDNA 3.1). For
each transfection, the percent cell survival for pCDNA3.1 was subtracted from
values for the other plasmid transfections because previous studies have dem-
onstrated that not all cells undergo apoptosis when they are treated with FB1 or
C6-ceramide (5, 52). The resulting values were averaged, thus providing the
mean difference for cell survival (n 5 7). Error bars represent the standard error
of the mean difference. (A) P values for CV-1 cells treated with the indicated
plasmids and treated with C6-ceramide were as follows: LRTwt, 0.0001; CpIAP,
0.0001; and EIA, 0.101. P values for transfected CV-1 cells treated with FB1 were
as follows: LRTwt, 0.0001; CpIAP, 0.0001; and EIA, 0.150. (B) P values for
transfected IMR-90 cells treated with C6-ceramide were as follows: LRTwt,
0.0001; CpIAP, 0.0001; and EIA, 0.072. P values for transfected IMR-90 cells
treated with FB1 were as follows: LRTwt, 0.0001; CpIAP, 0.0001; and EIA, 0.080.
The difference in values between LRTwt and CpIAP in panels A and B had a P
value of 0.619 (average).
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independent of treatment with C6-ceramide or FB1. In sum-
mary, these studies indicated that LR gene products promoted
survival of CV-1 and IMR-90 cells after treatment with C6-
ceramide or FB1.
Identification of LR gene sequences that inhibit PCD. Three
LR gene mutants were constructed to further characterize the
sequences that were necessary to inhibit PCD (Fig. 3). LRT-
stop contains three in-frame stop codons at the amino termi-
nus of LR ORF2 and thus should prevent translation of any
ORF encoded by a LR RNA. Insertion of stop codons at this
position was previously shown to prevent expression of a 40-
kDa protein that was recognized by a LR ORF2-specific anti-
body P2 (21). Plasmid LRTDSmaI has a 258-bp SmaI deletion
that spans the intron/exon borders of LR RNA (8, 21). In
LRTDHX, 523 bp of the LR promoter was deleted. To test
whether these constructs synthesized LR RNA, CV-1 cells
were transfected, RNA was prepared 48 h after transfection,
and RT-PCR was performed with LR-specific primers L3A
and L3B (Fig. 3C). As expected, LRTwt synthesized RNA that
was amplified with primers L3B (Fig. 4A, lane 5) and L3A (Fig.
4B, lane 5). L3A (Fig. 4B) and L3B (Fig. 4A) primers also
amplified a similar-sized cDNA fragment, using RNA pre-
pared from CV-1 cells transfected with LRTDHX (lane 2),
LRTstop (lane 3), or LRTDSmaI (lane 4). These bands were
amplified cDNA because no bands were observed when RT
was omitted from the reaction (Fig. 4C). As expected, b-actin
RNA was amplified in every sample (Fig. 4D). Since primers
L3A and L3B are downstream of the SmaI restriction site (Fig.
3C), the SmaI deletion was not expected to interfere with
amplification of the 39 terminus of LR RNA.
Transient transfection of COS-7 (21, 46), U2-OS (27), and
293 (Fig. 5) cells with the LR gene leads to expression of a
40-kDa protein that is recognized by the P2 antibody. We
believe that the difficulty in detecting LRP in other transiently
transfected cells (CV-1, neuro-2A, and primary human fibro-
blasts) is due to lower transfection efficiency. However, it can-
not be ruled out that factors in these cell lines inhibit stable
expression of LRP or the protein is not expressed at detectable
levels (50). 293 cells transfected with LRTwt and LRTDHX
expressed a 40-kDa protein that was recognized by the P2
antibody (Fig. 5, lanes B and C, respectively). The same anti-
body did not recognize a 40-kDa protein in cells transfected
with LRTstop (lane D) or LRTDSmaI (lane E) or in mock-
transfected cells (lane A). Since COS-7, U2-OS, and 293 cells
are highly transformed and readily form tumors in immunode-
ficient mice, they are more resistant to apoptotic agents such as
FB1 and C6-ceramide. Consequently, these cell lines are not
good models for studies of apoptosis. In summary, all four
plasmids containing the LR gene constructs synthesized RNA
in CV-1 cells that was amplified by primers L3A and L3B. Only
LRTwt and LRTDHX expressed a 40-kDa protein in tran-
siently transfected 293 cells.
The b-Gal assay was then used to determine the effective-
ness of the different LR gene deletion constructs with respect
to protection against apoptotic agents (Fig. 6). Two different
cell lines, CV-1 and neuro-2A, were used for these studies.
CV-1 cells were treated with C6-ceramide whereas neuro-2A
cells required etoposide for induction of efficient PCD. LRTwt
and LRTDHX enhanced cell survival compared to pCDNA3.1
in CV-1 and neuro-2A cells. In contrast, LRTstop and
LRTDSmaI did not protect cells better then the vector alone in
neuro-2A cells. In CV-1 cells, LRTstop was not significantly
different from the vector control. The difference between
LRTDSmaI and the vector control was significantly different in
CV-1 cells, suggesting that truncated LR gene products pro-
moted PCD or cooperated with C6-ceramide to enhance cell
death. Etoposide and the transcription factor E2F cooperate to
induce PCD (39), indicating that these interactions can occur.
FIG. 3. Schematic of LR gene and mutants. (A) Locations of the LR gene and ORFs. The 59 ends of the LR RNA were mapped by RACE (rapid amplification
of cDNA ends) PCR or primer extension (3, 21). The vertical lines denote the 59 termini of the transcripts. In latently infected cattle, the 59 terminus of LR RNA has
additional leader sequences. Splicing of LR RNA (dashed lines) occurs within the region of the transcript that would eliminate the three stop codons of LR ORF2 (8,
21) and may yield transcripts that encode LRP isoforms. The two major ORFs are marked LR ORF 1 and LR ORF 2 (32). The other regions that have the potential
to encode a protein (u and n ) are in reading frames B and C respectively, but do not have a methionine residue at their amino termini. Asterisks indicate where
in-frame stop codons are located. (B) Partial restriction map of the 2-kb LR gene. Construction of the mutants is described in Materials and Methods. (C) Locations
of the LR primers used to detect LR RNA (21). Sequences of these primers are given in Materials and Methods.
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There was also an increase in CV-1 cell survival after trans-
fection with LRTDHX compared to LRTwt. This was not ob-
served in neuro-2A cells treated with etoposide and may reflect
differences in cell types or the mechanism by which etoposide
kills cells. In summary, this study demonstrated that LRTstop
and LRTDSmaI did not protect CV-1 and neuro-2A cells from
PCD but LRTwt and LRTDHX did.
DISCUSSION
This study provided evidence that LR gene products inhib-
ited PCD induced by C6-ceramide, FB1, or etoposide. Three
different cell types, including a cell line of neuronal origin,
were used. LRTstop and LRTDSmaI were unable to prevent
PCD in any cell type tested and did not express a 40-kDa
protein in 293 cells that was recognized by the P2 antibody.
Although it is tempting to speculate that expression of LRP is
required for preventing PCD, it is clear that LRTDSmaI and
LRTstop would express transcripts that are different from
those expressed by LRTwt and LRTDHX. Consequently, it
cannot be ruled out that subtle quantitative or qualitative dif-
ferences in the transcripts encoded by LRTDSmaI and LRT-
stop play a role in cell survival. Further studies are necessary to
prove that continual expression of LRP is necessary for inhib-
iting PCD.
The ability of LR gene products to inhibit cell cycle progres-
sion (46) and LRP to bind Cdk2/cyclins (27) may play a role in
preventing PCD. A link between cell cycle regulatory proteins
and PCD has been established. For example, cyclin A-depen-
dent kinase activity is stimulated during PCD (37), and PCD is
suppressed by dominant negative mutants of Cdk2 or Cdc2
(38). Second, cell cycle inhibitors promote survival of postmi-
totic neurons (41–43), and the Cdk inhibitor p21 can protect
cells from PCD (12, 36). Third, proteolytic enzymes that are
activated during PCD (caspases) induce cdk/cyclin activity in
the early stages of PCD (34, 55). Genes that regulate PCD,
Bcl-2 and BAX, modulate cdk2 activation during thymocyte
apoptosis (11). Finally, FB1 treatment of CV-1 cells induces a
transient increase in Cdk2 and Cdk4 activity (5). At this time,
the factors that direct cell cycle regulators to initiate PCD but
not cell cycle progression have not been identified.
FIG. 4. Detection of LR RNA in CV-1 cells transfected with the LR gene deletion plasmids. RT-PCR was performed with RNA prepared from CV-1 cells
transfected with pCDNA3.1 (lane 1), LRTDHX (lane 2), LRTstop (lane 3), LRTDSmaI (lane 4), and LRTwt (lane 5). In panels A and B, lane 6 was the no-template
reaction, lane 7 was a reaction containing LATwt plasmid DNA, and lane 8 was a 100-bp molecular weight marker. Numbers on the right are sizes of the markers in
base pairs. RT-PCR was performed as described in Materials and Methods. Amplified products were electrophoresed on 2% agarose gels. In panels A and B, RT-PCR
was performed with primers L3B (1.5 mM MgCl2) and L3A (1.0 mM MgCl2), respectively. Primers L3B will amplify a 197-bp product, and primer L3A will amplify
a 187-bp product (21). (C) The no-RT reaction using primers L3B. A similar result was obtained with primer L3A (50). (D) RT-PCR reactions amplified with b-actin
primers. The actin primers span an intron, which allows identification of genomic DNA and cDNA in the same sample. Genomic DNA yields a 1,091-bp amplicon,
whereas cDNA yields a 540-bp amplicon.
FIG. 5. Detection of a 40-kDa protein in cells transfected with LR gene
constructs. Human (293) cells were transfected with the designated plasmids,
whole-cell extract was prepared 48 h after transfection, and 50 mg of protein was
electrophoresed on an SDS–12% polyacrylamide gel. Extracts were prepared
from mock-transfected cells (A) and cells transfected with LRTwt (B), LRTDHX
(C), LRTstop (D), and LRTDSmaI (E). Locations of molecular weight markers
are shown at the left in kilodaltons. The arrow indicates the position of LRP.
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BHV-1 induces PCD in lymphocytes (14–17), bovine kidney
cells (9), and acutely infected cattle (53), suggesting that cells
in the peripheral nervous system undergo PCD. During patho-
logical states, neurons undergo PCD (10, 49, 54), indicating
they are usually resistant to PCD. LR RNA and LRP may
promote neuronal survival during establishment and mainte-
nance of latency (outlined in Fig. 7). The LR gene inhibits the
transactivation potential of bICP0 in transient transfection as-
says presumably because LR RNA interferes with bICP0 ex-
pression (3) and thus may interfere with productive infection.
The interaction between LRP and Cdk2 (28) may also repress
productive infection because roscovitine, a chemical that in-
hibits Cdk2, Cdc2, and Cdk5 activity (47, 48), inhibits HSV
transcription and DNA replication. Cdk2 activity is also re-
quired for initiation of cellular DNA replication (30). Based on
these observations, we hypothesize that LR RNA and LRP act
in concert to inhibit productive viral gene expression and neu-
ronal PCD during establishment and maintenance of latency.
During reactivation, LR gene products may promote neuro-
nal survival in the face of productive viral gene expression and
DNA replication, thus maximizing virion production. Only
20% of neurons latently infected with BHV-1 actually reacti-
vate following dexamethasone injection (44), suggesting that
80% of latently infected neurons resume latency. Thus, LR
gene products may enhance neuronal survival in the event of
incomplete reactivation. During reactivation, TG neurons may
be more vulnerable to PCD because dexamethasone inhibits
LR promoter activity (28), represses LR RNA expression in
TG but initiates viral gene expression (44), and induces PCD
(20). Considering LR RNA is alternatively spliced in neurons
(8), it is possible that reactivation-specific factors facilitate
reactivation. This hypothesis can be tested directly in cattle
when a LR-negative mutant is constructed.
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